Literature DB >> 3024007

Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.

B F Polk, R Fox, R Brookmeyer, S Kanchanaraksa, R Kaslow, B Visscher, C Rinaldo, J Phair.   

Abstract

In a cohort of 1835 homosexual men who were seropositive for human immunodeficiency virus (HIV) on entry into a prospective study, the acquired immunodeficiency syndrome (AIDS) developed in 59 during a median follow-up of 15 months. We matched 5 seropositive controls to each case according to study center and date of enrollment and performed a case-control analysis to determine factors predictive of AIDS. In a multivariate analysis, a decreased number of T helper lymphocytes, an increased number of T suppressor lymphocytes, a low level of antibody to HIV, a high titer of cytomegalovirus antibody, and a history of sex with someone in whom AIDS developed were independently associated with subsequent AIDS. Separate analyses of risk factors for Kaposi's sarcoma and opportunistic infections failed to support previously reported associations between the use of nitrites or an elevated cytomegalovirus-antibody titer and Kaposi's sarcoma. These variables may be markers rather than determinants of disease progression. A vigorous antibody response to HIV infection may confer at least temporary protection against the progression of immunodeficiency to AIDS, or a low level of antibody to HIV may reflect a later stage of infection. The increased risk associated with a history of sex with someone in whom AIDS developed may indicate earlier infection in cases or infection with a more virulent strain of HIV. These results may be useful in counseling HIV-seropositive persons and in designing studies of clinical interventions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3024007     DOI: 10.1056/NEJM198701083160201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  89 in total

1.  Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts.

Authors:  T Messele; M Abdulkadir; A L Fontanet; B Petros; D Hamann; M Koot; M T Roos; P T Schellekens; F Miedema; T F Rinke de Wit
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS.

Authors:  M J Gill; R Read
Journal:  Can J Infect Dis       Date:  1991

3.  Impact of CCR5delta32 host genetic background and disease progression on HIV-1 intrahost evolutionary processes: efficient hypothesis testing through hierarchical phylogenetic models.

Authors:  Diana Edo-Matas; Philippe Lemey; Jennifer A Tom; Cèlia Serna-Bolea; Agnes E van den Blink; Angélique B van 't Wout; Hanneke Schuitemaker; Marc A Suchard
Journal:  Mol Biol Evol       Date:  2010-12-06       Impact factor: 16.240

Review 4.  Randomised placebo controlled trials in HIV infection: to be or not to be?

Authors:  K Gelmon; I V Weller
Journal:  Genitourin Med       Date:  1989-06

5.  Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1.

Authors:  J D Mosca; D P Bednarik; N B Raj; C A Rosen; J G Sodroski; W A Haseltine; G S Hayward; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

6.  Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus.

Authors:  M G Davis; S C Kenney; J Kamine; J S Pagano; E S Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Prevalence of HIV infection in 646 heroin addicts and outcome of HIV-related conditions in the 266 followed up.

Authors:  C Mandelli; D Conte; R Barbera; T Masullo; S Pistoso; G P Aimo; L Cesarini; M Fraguelli; G P Lorini; P A Bianchi
Journal:  Eur J Epidemiol       Date:  1991-01       Impact factor: 8.082

8.  Variables influencing condom use in a cohort of gay and bisexual men.

Authors:  R O Valdiserri; D Lyter; L C Leviton; C M Callahan; L A Kingsley; C R Rinaldo
Journal:  Am J Public Health       Date:  1988-07       Impact factor: 9.308

Review 9.  Clinical pharmacology of zidovudine and other 2',3'-dideoxynucleoside analogues.

Authors:  F Kamali
Journal:  Clin Investig       Date:  1993-05

10.  HIV knowledge and risk behaviors among women in law enforcement in Bogota, Colombia: potential role as community educators.

Authors:  María Jose Míguez-Burbano; Ivette de Pool; Sonya Hadrigan; Jimmey Jackson; Ivan Angarita; Eddy Perez Then; Ximena Burbano; Gail Shor-Posner
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.